Skip to content

Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy

A Randomized Controlled Trial Comparing the Segmental Artery Clamping and Main Renal Artery Clamping During Laparoscopic Partial Nephrectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01892059
Enrollment
100
Registered
2013-07-03
Start date
2013-05-31
Completion date
2016-05-31
Last updated
2013-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Neoplasms, Renal Cell Carcinoma

Keywords

renal tumour, partial nephrectomy, laparoscope, segmental renal artery clamping

Brief summary

The purpose of this study is to compare the efficacy and safety of the segmental artery clamping and main renal artery clamping during laparoscopic partial nephrectomy

Detailed description

Renal tumor patients,for whom laparoscopic partial nephrectomy is suitable, will be randomly divided into two groups,segmental artery clamping group and main artery clamping group. All procedures were performed by the same laparoscopic surgeon. Blood loss, operation time, warm ischemia time, complications and affected renal function before and after operation will be recorded and compared. The safety and efficiency of laparoscopic partial nephrectomy with segmental renal artery clamping will be evaluated in comparison with the conventional main renal artery clamping technique.

Interventions

PROCEDURESegmental artery clamping

Laparoscopic partial nephrectomy with segmental artery clamping will be performed for patients enrolled in this group.

PROCEDUREMain renal artery clamping

Laparoscopic partial nephrectomy with main renal artery clamping technique will be performed for patients enrolled in this group.

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* 20\<age\<70yr * Stage T1a * Patients volunteered for this study and provided written informed consent

Exclusion criteria

* Bilateral renal tumor * tumor of solitary kidney * glomerulonephritis * renal insufficiency * GFR of invalid kidney less than 30ml/min * presence of suspect metastasis * serious systematic disease: severe coagulation disorders * important organ insufficiency and severe psychological disease

Design outcomes

Primary

MeasureTime frame
Glomerular Filtration Rate3 months postoperative

Secondary

MeasureTime frame
warm ischemia timeduring surgery

Other

MeasureTime frame
estimated blood lossduring surgery

Countries

China

Contacts

Primary ContactChangjun Yin, MD, PHD
lee_lipu@163.com+86 25-68136319
Backup ContactPengfei Shao, MD, PHD
spf032@hotmail.com+86 25-68136851

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026